IL18BP and ovarian carcinoma: Similarly, IL-27 was found to induce the expression of immune-regulatory molecules such as IL-18BP, the natural inhibitor of IL-18, and PD-L1 and IDO in human ovarian cancer cells [42, 43] and also in other cancer cells in vitro.